Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Breast Screening

Interventions: Other: Clinical Breast exam (CBE)
Device: iBreastExam device
Diagnostic Test: mammogram

First Posted Date: 2021-02-18

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 310

Registration Number: NCT04761055

Locations: 🇺🇸
MSK at Ralph Lauren (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

Phase 2

Active, not recruiting

Conditions: Esophagogastric Cancer
HER2-Negative

Interventions: Drug: regorafenib
Drug: nivolumab
Drug: FOLFOX chemotherapy with oxaliplatin

First Posted Date: 2021-02-17

Last Posted Date: 2025-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT04757363

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Not Applicable

Recruiting

Conditions: Pancreatic Cancer
Ovarian Cancer
Prostate Cancer
Educational Materials for Genetic Testing
Breast Cancer

Interventions: Other: Cognitive interview

First Posted Date: 2021-02-12

Last Posted Date: 2025-05-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 625

Registration Number: NCT04751435

Locations: 🇺🇸
Jamaica Hospital Medical Center (Data Collection Only), Richmond Hill, New York, United States
🇺🇸
Kings County Hopsital Center, Brooklyn, New York, United States
🇺🇸
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States

and more 1 locations

A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

Recruiting

Conditions: Skin Lesion
Mucosal Lesion

Interventions: Diagnostic Test: Dermoscopic imaging
Diagnostic Test: 3-dimensional total body photography
Diagnostic Test: Confocal microscopy
Diagnostic Test: Optical Coherence Tomography imaging
Diagnostic Test: Ultrasound
Diagnostic Test: Hyperspectral imaging
Diagnostic Test: Electrical impedance spectroscopy
Diagnostic Test: Patient self-imaging

First Posted Date: 2021-02-08

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5010

Registration Number: NCT04743362

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Using e-Nose Technology to Identify Early Lung Cancer

Active, not recruiting

Conditions: Lung Cancer
Lung; Node

Interventions: Diagnostic Test: Breathprinting test

First Posted Date: 2021-02-02

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 119

Registration Number: NCT04734145

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States

and more 4 locations

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Phase 2

Active, not recruiting

Conditions: Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions: Drug: Acalabrutinib
Drug: Obinutuzumab

First Posted Date: 2021-01-25

Last Posted Date: 2025-03-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT04722172

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States

and more 5 locations

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Phase 1

Recruiting

Conditions: Head Cancer Neck
Head and Neck Squamous Cell Carcinoma
Neck Cancer
HNSCC
Head Cancer
Head and Neck Cancer

Interventions: Drug: Cisplatin
Drug: Carboplatin
Drug: Docetaxel
Drug: Cetuximab
Drug: Cemiplimab
Procedure: Surgical Resection of Primary +/- Neck Dissection
Radiation: Post-operative radiation therapy
Drug: Paclitaxel

First Posted Date: 2021-01-25

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT04722523

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Phase 2

Active, not recruiting

Conditions: NSCLC
Non-small Cell Lung Cancer
Lung Cancer
Non-small Cell Lung Cancer Stage I
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage IIIA
Non-small Cell Lung Cancer Stage III
PD-L1 Gene Mutation

Interventions: Drug: Durvalumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2021-01-20

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 13

Registration Number: NCT04716946

Locations: 🇺🇸
Hartford Healthcare (Data Collection), Hartford, Connecticut, United States
🇺🇸
Baptist Alliance - McI, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 6 locations

Comparing Two Different Surgical Techniques for Breast Reconstruction

Phase 3

Withdrawn

Conditions: Breast Reconstruction

Interventions: Procedure: Prepectoral Prosthetic Breast Reconstruction
Procedure: Subpectoral Prosthetic Breast Reconstruction

First Posted Date: 2021-01-20

Last Posted Date: 2022-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT04716959

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Consent and Followup ), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent and Followup), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Followup), Harrison, New York, United States

and more 4 locations

Study of the Nevisense Device to Assess Atypical Skin Lesions

Active, not recruiting

Conditions: Nevus
Skin Lesion
Multiple Nevi
Large Acquired Nevi

Interventions: Diagnostic Test: Nevisense electrical impedance spectroscopy

First Posted Date: 2021-01-12

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT04705168

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy